- Low platelet counts are caused by primary immune thrombocytopenia (ITP) or hepatitis C virus (HCV) infection.
- Severe aplastic anemia
Revolade 25mg
MRP | : |
|
Price | : | ₹7,200.00 |
You Save | : | ₹628.13 (8.02%) |
7.0 tablets in 1 strip
Revolade 25mg tablet is an anticoagulant medication that falls under the category of thrombopoietin (TPO) receptor agonists, featuring the active ingredient Eltrombopag. It is utilized to address low platelet counts resulting from primary immune thrombocytopenia (ITP) or hepatitis C (HCV) infection. ITP is an autoimmune condition where the immune system attacks and destroys platelets.
Platelets are essential blood cells that facilitate clotting and safeguard the walls of blood vessels. A deficiency in platelet levels can lead to significant bleeding and bruising. Additionally, this tablet is prescribed to adults for treating low blood counts associated with severe aplastic anaemia, a critical blood disorder characterized by the bone marrow’s inability to produce sufficient new blood cells.
This medication is contraindicated for individuals with known hypersensitivity or allergic reactions to it or its components. Allergic responses can vary from mild to severe, potentially manifesting as rash, itching, swelling, dizziness, or breathing difficulties. Revolade 25mg tablets are not suitable for patients with severe liver impairment or active liver disease, as the drug may induce hepatotoxicity, indicated by elevated liver enzymes and bilirubin levels.
Administering this drug to individuals with severe liver disease may exacerbate liver function, thus caution is warranted. Your physician will recommend monitoring for cataracts, and if you do not undergo regular eye examinations, they should arrange for consistent testing. You may also be evaluated for bleeding in or around your retina, which is the light-sensitive layer of cells located at the back of the eye.
Should you discontinue this tablet, your blood platelet count is likely to drop again within a few days. Your platelet levels will be closely monitored, and your doctor will discuss necessary precautions. An excessively high platelet count may elevate the risk of blood clotting; however, blood clots can also develop with normal or even low platelet counts. Your physician will modify your dosage of this medication to ensure that your platelet count remains within a safe range.
Do not take